Advanced Search

Technical Analysis for NBTX - Nanobiotix S.A.

Grade Last Price % Change Price Change
D 18.75 5.34% 0.95
NBTX closed up 5.34 percent on Friday, January 15, 2021, on 65 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical NBTX trend table...
Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Fell Below 20 DMA Bearish 5.34%
Hot IPO Pullback Bullish Swing Setup 5.34%
Outside Day Range Expansion 5.34%
Down 3 Days in a Row Weakness 5.34%
Down 4 Days in a Row Weakness 5.34%
Narrow Range Bar Range Contraction 2.40%
NR7 Range Contraction 2.40%
Down 3 Days in a Row Weakness 2.40%
Outside Day Range Expansion -0.37%
Older End-of-Day Signals for NBTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Hot IPO Pullback Entry 2 days ago
Rose Above Previous Day's High 2 days ago
2x Volume Pace 2 days ago
1.5x Volume Pace 2 days ago
Up 1 ATR 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

Is NBTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 15 Nanobiotix Announces Positive First Results for Novel NBTXR3 in Rectal Cancer Study at ASCO-GI 2021
Jan 15 Nanobiotix's NBTXR3 shows positive action in rectal cancer study
Jan 8 NANOBIOTIX plans late-stage NBTXR3 study in head & neck cancer in 2021
Jan 8 Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering
Dec 17 The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
Dec 11 Nanobiotix prices global offering, U.S. shares to begin trading December 11
Dec 7 Nanobiotix Pursues $96 Million IPO Plan
See more NBTX news...

Indicators

Indicator Value
52 Week High 21.55
52 Week Low 15.89
Average Volume 54,761
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 17.90
10-Day Moving Average 18.47
Average True Range 1.53
ADX 0.0
+DI 24.10
-DI 12.91
Chandelier Exit (Long, 3 ATRs ) 16.96
Chandelier Exit (Short, 3 ATRs ) 20.69
Upper Bollinger Band 19.96
Lower Bollinger Band 15.84
Percent B (%b) 0.71
BandWidth 23.05
MACD Line 0.47
MACD Signal Line 0.35
MACD Histogram 0.1243
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.12
Resistance 3 (R3) 20.24 19.90 19.89
Resistance 2 (R2) 19.90 19.56 19.84 19.81
Resistance 1 (R1) 19.33 19.34 19.16 19.21 19.74
Pivot Point 18.99 18.99 18.91 18.93 18.99
Support 1 (S1) 18.42 18.65 18.25 18.30 17.76
Support 2 (S2) 18.08 18.43 18.02 17.69
Support 3 (S3) 17.51 18.08 17.61
Support 4 (S4) 17.39